LON:AOM - Activeops PLC
Executive Summary
ActiveOps PLC is a UK-listed software company that sells workforce management (WFM) software on a subscription basis to contact centres and back-office operations, primarily in financial services, healthcare, and retail. The platform covers scheduling, attendance, performance analytics, and compliance reporting. Within its niche, the company occupies a mid-sized position between spreadsheet-based scheduling and the larger enterprise WFM vendors, with a footprint in the UK, North America, and Australia/New Zealand.
The investment case rests on continued annual recurring revenue (ARR) expansion offsetting the current loss-making P&L, with the next near-term catalyst being the full-year results announcement (timing disclosed in the company's trading update of late 2026). What has to go right is sustained ARR growth and a credible path to profitability; the primary risk is that limited scale and liquidity, as flagged in the company's own disclosures, constrain the ability to compete against larger WFM vendors.
OPPORTUNISTIC BUY. Conviction Score: 59/100. The view would change to a higher-conviction Buy on evidence of accelerating ARR growth, improving operating margins, or a sizeable contract win from a tier-one enterprise client; it would change to a Sell on a deteriorating net retention rate, a dilutive raise, or ARR growth deceleration below the company's recent run-rate.
Thesis break: ARR growth decelerating below 10% for two consecutive reporting periods, a dilutive equity raise, or the loss of a named tier-one financial services or healthcare client.
Business Model
ActiveOps generates revenue almost entirely through SaaS subscriptions, charged per agent seat or per module on multi-year contracts (typically one to three years). The platform is sold on a land-and-expand basis: clients typically start with a single scheduling module and broaden adoption over time to include attendance, performance analytics, and compliance reporting. This dynamic drives expansion revenue within existing accounts and lifts average contract value as customers mature.
The customer base is concentrated in regulated industries with high workforce complexity - large financial services institutions, healthcare trusts, and retail organisations - where the cost of switching is elevated by integration with payroll, HR, and operational systems. Pricing is set per agent seat or per module, and contract durations are typically multi-year, producing a high proportion of recurring revenue in the income mix. The company's mid-market positioning in the UK and ANZ, with growing North American exposure, means it competes both with spreadsheet-based scheduling (which it displaces) and with larger enterprise WFM vendors at the upper end of the market.
The reported net margin of 4.41% and negative trailing P/E reflect a business that is still investing ahead of scale, with restructuring costs of GBP 1.2m incurred in the recent full-year period following the Enlighten acquisition. The competitive moat rests on customer stickiness in regulated workflows and on accumulated process expertise in complex scheduling environments rather than on any single technological lead. Forward consensus flagged by Simply Wall St points to revenue growth of 12.3% per annum and earnings growth of 102.9% per annum, consistent with a margin recovery story rather than a hyper-growth SaaS profile.
Financial Snapshot
Recent Catalysts
[20 February 2026] - Insider Richard John Jeffery purchased 54 shares of ActiveOps stock, a small but directionally notable insider buy reported by regulatory news services. Source: Defense World.
[19 February 2026] - The same insider purchase of 54 shares by Richard John Jeffery was reported, with the disclosure also referencing the company's net margin of 4.41% and return on equity of 0.01%. Source: Daily Political.
[11 January 2026] - ActiveOps shares were down 1.6% on the day, with the accompanying coverage noting the company had reported EPS of GBX (1.31) for the quarter alongside a 4.41% net margin and 0.01% return on equity. Source: Markets Daily.
[Late 2026] - ActiveOps announced a full-year trading update and notice of results, confirming the acquisition of Enlighten and flagging GBP 1.2m of restructuring costs incurred during the period. Source: Investegate (Company Announcement via RNS).
[2026] - ActiveOps agreed to sell the WorkiQ trademarks to Microsoft for $10 million, a discrete monetisation event that crystallises value from a non-core asset. Source: TipRanks (company announcement).
[2026] - ActiveOps acquired Enlighten Group Pty Ltd, an Australian acquisition intended to extend the company's footprint in the ANZ market. Source: London Stock Exchange news article (RNS).
Thesis Evaluation
Bull Case (25% weight)
ARR growth re-accelerates above 20% as the Enlighten acquisition cross-sells into the existing UK and North American base, net retention climbs above 110%, and the operating margin inflects towards break-even. The $10m WorkiQ trademark monetisation funds incremental product investment without dilution. Target: 290p within 12 months.
Base Case (50% weight)
ARR compounds in the low-to-mid teens with steady net retention around 105%, the Enlighten integration is absorbed within 12 months, and operating losses narrow but persist. The shares rerate modestly on improving SaaS unit economics. Target: 230p within 12 months.
Bear Case (25% weight)
ARR growth decelerates into single digits as the Enlighten integration distracts management, net retention slips below 100%, and the company is forced to raise capital to fund the cost base, creating dilution. Target: 150p within 12 months.
Key Risks
- Scale and liquidity risk: The company has flagged limited scale and liquidity in its own disclosures, which materially constrain the ability to compete against larger WFM vendors. Estimated probability: 35%. Impact: severe.
- Customer concentration and churn: A meaningful share of revenue comes from financial services and healthcare clients; loss of a top-tier account could materially impair ARR and reset the growth narrative. Estimated probability: 20%. Impact: severe.
- Continued unprofitability and capital risk: A negative trailing P/E of -61.46 reflects ongoing losses; if margin recovery stalls, a dilutive equity raise becomes plausible. Estimated probability: 25%. Impact: moderate.
- Integration risk from Enlighten acquisition: The Enlighten acquisition includes GBP 1.2m of restructuring costs and execution risk; a bungled integration could compress margins and distract management. Estimated probability: 30%. Impact: moderate.
- AIM listing liquidity and institutional accessibility: A mid-cap AIM listing limits institutional ownership and can produce wider spreads, which can amplify drawdowns on negative news. Estimated probability: 40%. Impact: low.
- Competitive pressure from enterprise WFM vendors: Larger well-capitalised WFM vendors can outspend ActiveOps on product, sales, and marketing, eroding the land-and-expand advantage over time. Estimated probability: 35%. Impact: moderate.
Who Should Own It / Avoid It
Ideal for: A growth-oriented investor with a 12-24 month horizon, a high tolerance for execution risk and unprofitable SaaS exposure, and a willingness to hold through interim losses in pursuit of an ARR-led rerating. The position is best suited to portfolios that already hold profitable, cash-generative large-cap software and can absorb five to ten percentage points of portfolio-level drawdown without forced selling.
Avoid if: You require current profitability, a multi-year track record of positive free cash flow, or exposure only to companies with a market capitalisation above GBP 500m. The position is also unsuitable for investors who cannot tolerate the AIM-specific liquidity premium, who need a dividend, or who would be forced sellers on a 20-30% drawdown.
Recommendation
BLOCKED - methodology gate failed (frameworkRuleCheck). The model score is 59/100 (OPPORTUNISTIC BUY), but this is not an actionable recommendation until the gate is verified.
Entry levels under review.
Conviction Trend
Latest conviction: 59/100. Trend versus prior report: Up.
| Report date | Conviction |
|---|---|
| 2026-08-08 | 59 |
| 2026-07-25 | 54 |
| 2026-06-28 | 59 |
| 2026-05-30 | 73 |
| 2026-04-28 | 59 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Public news flow drawn from regulatory news service announcements on the London Stock Exchange, company press releases, investor relations materials, and financial news wires covering insider transactions, share price moves, and corporate actions. Forward earnings and revenue growth references are drawn from third-party analyst aggregators, with the underlying figures traceable to the company's own reporting.
Primary source types: Regulatory announcements filed via RNS on the London Stock Exchange, company press releases and investor relations disclosures, the ActiveOps investor relations website, and Tier-1 financial news wires reporting on insider transactions and corporate actions.
Key sources
- ACTIVEOPS PLC ORD 0.1P (AOM.L) H2 FY2026 earnings call transcript
- ActiveOps (LON:AOM) Trading 0.5% Higher - Here's What Happened - Markets Daily
- ActiveOps PLC (AOM) Stock Forecast & Price Target - Investing.com
- AOM Stock Forecast - ActiveOps PLC - Alpha Spread
- ActiveOps Plc (AOM.L) Stock Price, News, Quote & History - Yahoo Finance
- ACTIVEOPS PLC AOM Stock | London Stock Exchange
- ActiveOps (AOM) Competitors and Alternatives 2025 $AOM
- ActiveOps 2026 Company Profile: Stock Performance & Earnings | PitchBook
- ActiveOps Sets Date for Full-Year Results and Investor Briefings - TipRanks.com
- Notice of Results | Company Announcement | Investegate
Data correct as of 2026-08-08